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DObjective:Artificial chordal replacement has been shown to be effective and durable, with numerous techniques
reported. However, the outcomes of each technique have remained poorly defined. We report the long-term
outcomes of the tourniquet technique.
Methods: We reviewed the data from 700 patients who had undergone mitral valve repair with the tourniquet
technique from 1992 to 2010. We analyzed the operative outcomes, long-term survival rate, freedom from
reoperation, and freedom from recurrent moderate or severe mitral regurgitation (MR). We also performed
Cox regression analysis to explore the predictors of recurrent MR after mitral valve repair using the tourniquet
technique.
Results: Themeanagewas 54.7 14.9 years; 212patients (30.3%) had anterior leaflet prolapse, 142 (20.3%) had
posterior leaflet prolapse, and 346 (49.4%) had bileaflet prolapse. Operative mortality was 1.3%. In 26 cases
(3.7%), mitral valve repair was unsuccessful and was converted to replacement. Of those successfully repaired,
the 12-year survival rate, freedom from mitral reoperation, freedom from recurrent moderate or severe MR,
and freedom from recurrent leaflet prolapsewas 85.9%, 88.7%, 72.3%, and 89.0%, respectively. The significant
predictors of recurrent MR were anterior leaflet prolapse, age, New York Heart Association class III or IV, left
ventricular end-systolic dimension, no annuloplasty ring or band, and postoperative residual mild or greater MR.
Conclusions: The tourniquet technique is a simple and effective method to repair leaflet prolapse, with a low
incidence of recurrent prolapse. The incidence of recurrent MR was high in the anterior leaflet prolapse
group. Age, no annuloplasty ring or band, and residual MR were strong predictors of recurrent MR. (J Thorac
Cardiovasc Surg 2014;148:2033-8)Supplemental material is available online.
Mitral valve repair has been the reference standard therapy
for severe degenerative mitral regurgitation (MR). Artificial
chordal replacement using expanded polytetrafluoroethy-
lene (ePTFE) sutures was introduced in the 1980s1 and
has been widely performed since then. The decision
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The Journal of Thoracic and Carfor successful repair, and numerous techniques have been
developed to determine the appropriate length of the artifi-
cial chordae. Although artificial chordal replacement has
been shown to be effective and durable, the outcomes of
each technique have not been well reported.
The tourniquet technique was introduced by Kasegawa
and colleagues2 in 1992 as a simple method to determine
the artificial chordal length. We have been using this tech-
nique for artificial chordal replacement since then. In the
present study, we analyzed the early and late outcomes of
mitral valve repair using the tourniquet technique and eval-
uated the effectiveness and durability of this technique. We
also explored the predictors of recurrent MR after mitral
valve repair using this technique.METHODS
Study Design and Patient Data
The present study was a retrospective cohort study. The institutional re-
view board of Sakakibara Heart Institute approved the study and waived the
requirement for informed consent.
From January 1992 to December 2010, 1112 adult patients underwent
mitral valve repair for type II MR at our institution. Of the 1112 patients,
700 underwent mitral valve repair using the tourniquet technique. We
excluded pediatric patients<18 years old at surgery from the present study.diovascular Surgery c Volume 148, Number 5 2033
Abbreviations and Acronyms
CI ¼ confidence interval
ePTFE ¼ expanded polytetrafluoroethylene
HR ¼ hazard ratio
MR ¼ mitral regurgitation
TTE ¼ transthoracic echocardiography
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The outcomemeasures included operative mortality, intraoperative con-
version to mitral valve replacement, residual mild or greaterMR on the pre-
discharge transthoracic echocardiogram (TTE), long-term survival,
freedom from mitral reoperation, freedom from recurrent moderate or
severe MR, and freedom from recurrent mitral leaflet prolapse. All long-
term and echocardiographic outcomes were analyzed, excluding 26
patients who had undergone mitral valve replacement in their primary sur-
gery. Operative mortality was defined as death within 30 days after surgery
or before discharge. Survival was calculated from surgery until death, and
patients alive were censored at the point of last contact. The mean follow-
up period was 80  55 months after surgery, and 94% of patients had
complete follow-up data available.
Operative Technique and Intraoperative TEE
Surgery was performed through a median sternotomy or right minithor-
acotomy. All surgery was performed using cardiopulmonary bypass and
cardioplegic arrest. The mitral valvewas accessed through a superior trans-
septal approach in median sternotomy cases and through a standard left
atriotomy in minithoracotomy cases. Mitral annuloplasty using a ring or
band was routinely performed; however, a few patients did not undergo
mitral annuloplasty in the early study period. Posterior leaflet prolapse
was primarily repaired with leaflet resection with or without sliding valvu-
loplasty, and artificial chordae were added as a supplementary procedure, if
necessary. In this cohort, only a few patients underwent artificial chordal
replacement without resection of the posterior leaflet. Anterior leaflet pro-
lapse was primarily repaired with artificial chordal replacement using the
tourniquet technique.
To implant artificial chordae, we first fixed CV5 ePTFE sutures (L. Gore
& Associates, Inc, Flagstaff, Ariz) on the correspondent papillary muscle
head in a pledgeted mattress fashion. Next, we passed 2 ends of the suture
through the prolapsing segment of the leaflet. After seating the annulo-
plasty ring or band, we placed small tourniquets on each pair of artificial
chordae, held them at a specific length by approximating the normal adja-
cent chordae, and assessed the leaflet competency by injecting saline into
the left ventricle (Figure E1). We monitored the left ventricular volume
using TEE and filled the left ventricle to the approximate end-systolic vol-
ume. If the saline testing showed poor competency, we would readjust the
length by sliding the tourniquet and reassess the leaflet competency with
saline testing. Once we had confirmed good competency, we gently
clamped the ePTFE sutures just below the lower end of the tourniquet
with a right-angled clamp, removed the tourniquets, and tied the sutures.
We used a very thin and light tourniquet tube for this technique
(Figure E2). The tourniquet tube we have used is 1.0 mm in inner diameter,
1.7 mm in outer diameter, and 1 g in weight. If the tourniquet is too thick or
too heavy, it will deform the valve during saline testing, making it difficult
to assess leaflet competency.
After the repair, the mitral valve was evaluated using intraoperative
TEE. Repeat repair or mitral valve replacement with chordal preservation
was performed at the same operation if the intraoperative TEE showed sig-
nificant residual MR after repair. For quick screening of residual MR, the
MR jet area was measured. Our indication for a second cardiopulmonary2034 The Journal of Thoracic and Cardiovascular Surbypass pump run for repeat repair or replacement was>2.0 cm2 of MR
jet area before 2006 and>1.0 cm2 since 2006.
TEE Study
TTE studies were performed before surgery, before discharge, and dur-
ing follow-up. The mean TEE follow-up period was 64  56 months, and
662 patients (98.2%) underwent 1 TTE after discharge. We reviewed
3424 TEE studies. The left ventricular ejection fraction was calculated us-
ing the biplane Simpson method. The left ventricular end-systolic dimen-
sion was measured from the 2-dimensional parasternal long-axis view.
An effective MR orifice area was calculated as the ratio of MR flow to
regurgitant velocity using the proximal isovelocity surface area method.
The MR grade was quantitatively determined according to the American
College of Cardiology/American Heart Association 2006 guidelines.3
When the quantitative assessment of MR was not applicable, MR severity
was determined semiquantitatively using other parameters such as the vena
contracta and MR jet area.4 Residual MR was defined as mild or greater
MR on the postoperative predischarge TTE. Recurrent MR was defined
as moderate or severe MR on any TTE after surgery.
Statistical Analysis
Continuous variables are expressed as the mean standard deviation if
normally distributed or as the median otherwise. For the time-to-event out-
comes (survival, cardiac adverse event-free rate, and freedom from recur-
rent MR), the interval to a first event was compared using the log-rank test,
and the Kaplan-Meier method was used to estimate the absolute risk of
each event for each group. Stepwise Cox regression models were used to
explore the predictors of recurrent MR. We included the following vari-
ables in the model: anterior leaflet prolapse, posterior leaflet prolapse
(bileaflet prolapse was the reference for prolapse location), age, hyperten-
sion, atrial fibrillation, NewYork Heart Association class III or IV, a history
of endocarditis, ejection fraction, left ventricular end-systolic dimension,
no annuloplasty ring or band used, and postoperative residualMR. The haz-
ard ratios (HRs) and 95% confidence intervals (CIs) were estimated. All
comparisons were planned, and the tests were 2-sided. All statistical ana-
lyses were performed by using PASW 18.0 (SPSS Inc, Chicago, Ill).
RESULTS
Preoperative Characteristics
The mean age of all patients was 54.7  14.9 years, and
230 patients (32.9%) were women. Isolated anterior leaflet
prolapse was present in 212 patients (30.3%), isolated pos-
terior leaflet in 142 (20.3%), and bileaflet prolapse in 346
patients (49.4%). The preoperative characteristics of the
patients are listed in Table 1.
Operative Results
The operative data are listed in Table 1. In the present
cohort, 661 cases (94.4%) were performed by way of a me-
dian sternotomy and 39 cases (5.6%) using a right minithor-
acotomy. Concomitant cardiac procedures were performed
in 260 patients (37.1%). For mitral valve repair, we per-
formed artificial chordal placement using the tourniquet
technique in all cases, and the median number of leaflet
segments in which artificial chordae were placed was 2 seg-
ments (range, 1-7). We also performed concomitant mitral
annuloplasty with a ring or band in 680 patients (97.1%),
and leaflet resection with or without sliding valvuloplasty
in 473 patients (67.5%). We repeated the cardiopulmonarygery c November 2014
TABLE 1. Preoperative characteristics of patients and operative data
(n¼700)
Variable Value
Mean age (y) 54.7  14.9
Women 230 (32.9)
NYHA class III or IV 230 (32.9)
Atrial fibrillation 120 (17.1)
Hypertension 217 (31.0)
History of endocarditis 81 (11.6)
Emergency surgery 7 (1.0)
Mean LVEF (%) 65.1  9.0
Mean LVESD (mm) 35.4  4.9
Anterior leaflet prolapse 212 (30.3)
Posterior leaflet prolapse 142 (20.3)
Bileaflet prolapse 346 (49.4)
Concomitant procedure 260 (37.1)
Aortic valve replacement 12 (1.7)
Tricuspid valve repair 140 (20.0)
Ablation surgery 114 (16.3)
Coronary artery bypass grafting 45 (64.3)
Thoracic aortic surgery 12 (1.7)
Median number of leaflet segment repaired with artificial
chordae
2 (1-7)
Concomitant mitral valve procedures 698 (99.7)
Leaflet resection with or without sliding valvuloplasty 473 (67.6)
Mitral annuloplasty using a ring or band 680 (97.1)
Repeated cardiopulmonary bypass runs for residual MR 62 (8.9)
Conversion to mitral valve replacement 26 (3.7)
Data presented as mean standard deviation, median (range), or n (%). NYHA, New
York Heart Association; LVEF, left ventricular ejection fraction; LVESD, left ventric-
ular end-systolic dimension; MR, mitral regurgitation.
TABLE 2. Reasons for mitral valve reoperation (n ¼ 48)
Reason n (%)
Recurrent mitral regurgitation from all causes 39
Prolapse (prolapse with ruptured artificial chordae) 17 (3)
Degenerative changes without prolapse 19
Mechanical problems of primary repair procedure 3
Hemolysis 3
Infective endocarditis 4
Other 2
Left ventricular pseudoaneurysm 1
Leaflet suture line dehiscence with mild MR 1
MR, Mitral regurgitation.
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patients (8.2%). We converted the procedure to mitral valve
replacement for failed repair in 26 patients (3.7%). The rea-
sons of conversion were residual MR that was difficult to
repair in 22 patients, systolic anterior motion in 2, papillary
muscle rupture in 1, and left ventricular rupture in 1 patient.
The operative mortality was 1.3% (9 of 700). Six opera-
tive deaths occurred in those undergoing mitral valve repair.
The cause of death for those 6 patients was respiratory com-
plications in 3, postcardiotomy cardiogenic shock in 1,
stroke in 1, and sepsis in 1. Three operative deaths occurred
in cases converted to mitral valve replacement. The cause of
deaths for those 3 patients was left ventricular rupture, post-
cardiotomy cardiogenic shock, and ventricular arrhythmia
in 1 each.Early TTE Findings
All patients had undergone a postoperative predischarge
TTE. Excluding the 26 patients who had undergone conver-
sion to mitral valve replacement, 82 patients (12.2%) had
mild or greater MR. The incidence of residual MR
decreased dramatically from 24.4% (57 of 294) before
2006 to 6.6% (25 of 380) after 2006, in accordance withThe Journal of Thoracic and Carimprovements in surgical skill and the quality of the intra-
operative TEE assessment. Residual leaflet prolapse was
found only in 5 patients (0.7%). Thus, most residual MR
had resulted from poor coaptation, despite the appropriate
artificial chordal length. All 82 patients with residual MR
had undergone serial follow-up TEE examinations. During
the follow-up period, residual MR worsened in 39 patients
(47.6%), stayed unchanged in 29 (35.4%), and improved in
14 (17.1%).
Long-Term Survival and Mitral Valve Reoperation
The actuarial survival rate was 93.8% at 7 years and
85.9% at 12 years. The freedom from mitral reoperation
rate was 96.4% at 7 years and 88.7% at 12 years. A total
of 48 mitral reoperations were performed during the
follow-up period. Three patients were found to have
ruptured artificial chordae, and they underwent reoperation
at 4, 7, and 84 months after the primary mitral valve repair.
In all 3 cases, the rupture of the artificial chordae had
occurred at the middle portion of the chordae, which was
not the portion we had clamped during the primary surgery.
We only repaired the mitral valve again in 7 patients and re-
placed the valve in 41 patients, mostly because of advanced
degenerative disease. The reasons for the mitral reopera-
tions are listed in Table 2.
Late TTE Findings
The follow-up TTEs showed that 94 of 674 patients had
developed recurrent moderate or severe MR. The median
interval to the recurrence of moderate or severe MR after
surgery was 94 months (range, 0-227). Of those 94 patients,
33 had recurrent prolapse, 47 had degenerative changes
without prolapse, 4 had infective endocarditis, and 10 had
other pathologic findings, such as ring detachment, dehis-
cence of leaflet suture, and leaflet perforation. The freedom
from recurrent moderate or severe MR rate was 82.6% at 7
years and 72.3% at 12 years (Figure 1). When stratified by
the preoperative prolapse location, the 10-year freedom
from recurrent MR rate was 63.5% in the anterior leaflet
prolapse group, 81.1% in the posterior leaflet prolapse
group, and 83.6% in the bileaflet prolapse groupdiovascular Surgery c Volume 148, Number 5 2035
FIGURE 1. Kaplan-Meier curve for freedom from recurrent moderate or
severe mitral regurgitation after mitral valve repair.
FIGURE 3. Kaplan-Meier curve for freedom from recurrent leaflet
prolapse after mitral valve repair.
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lapse rate was 95.1% at 7 years and 89.0% at 12 years
(Figure 3). Stepwise Cox regression analysis showed that
the significant predictors of recurrent MR were anterior
leaflet prolapse (HR, 2.0; 95% CI, 1.1-3.6; P ¼ .016), age
(HR, 1.05; 95% CI, 1.02-1.07; P ¼ .001), New York Heart
Association class III or IV (HR, 1.8; 95% CI, 1.1-2.9;
P ¼ .026), left ventricular end-systolic dimension (HR,
2.1; 95% CI, 1.3-3.4; P ¼ .004), no annuloplasty ring
or band used (HR, 4.0; 95% CI, 1.8-8.9; P ¼ .001), and
postoperative residual MR (HR, 5.2; 95% CI, 3.2-8.6;
P<.001).FIGURE 2. Kaplan-Meier curves for freedom from recurrent moderate or
severe mitral regurgitation after mitral valve repair stratified by prolapse
location.
2036 The Journal of Thoracic and Cardiovascular SurDISCUSSION
The tourniquet technique is a simple and reproducible
method to determine the length of artificial chordae. We
used this technique exclusively to adjust the chordal length
during the study period. Our study has shown that this tech-
nique is effective and durable for repair of leaflet prolapse.
One of the advantages of this technique is that it does not
require echocardiographic or direct measurement of the
chordal length. Many techniques using a fixed length of
artificial chordae have been introduced.5-10 In those
techniques, the fixed length is determined by preoperative
echocardiographic measurement or intraoperative direct
measurement using a caliper, both of which have a risk of
measurement error. Also, the locations at which the
sutures will be fixed on the papillary muscle and leaflet
could be different from the points of measurement. In
such cases, the fixed chordal length will not work well.
We have held the tourniquets at a specific length by refer-
ence to the normal adjacent chordae and readjusted the
length after saline testing if the competency was not
good. In some techniques, the chordal length will be deter-
mined by reference to the normal adjacent chordae without
testing.11,12 A disadvantage of such techniques is that the
chordal length cannot be corrected once a specific length
has been obtained. The optimal length of the artificial
chordae can be different from that of the adjacent normal
chordae. Other techniques will create artificial chordae of
adjustable length, such as in our technique.13-16 In those
techniques, the artificial chordae will be held at a specific
length using a temporary suture, a single loop or knot of
the suture on the leaflet, hemoclips, and neurosurgical
clips. Small light tourniquets will affect saline testing less
than will large clips and have a lower risk of being lost in
the chest than do small clips. Additionally, the chordalgery c November 2014
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up or down, which seems easier than undoing and redoing
temporary sutures or knots. The advantage of the
tourniquet technique is more apparent in minimally
invasive procedures because all aspects can be controlled
from outside the chest.
One of potential drawbacks of the tourniquet technique is
that clamping ePTFE sutures might reduce their tensile
strength. We found a ruptured artificial chorda in 3 mitral
reoperation cases. Those ruptures could have been caused
by intraoperative damage to the suture; however, none of
those had ruptured at the site that had been clamped in
the primary surgery. From our experience, gentle clamping
of ePTFE sutures using a right-angled clamp seems safe;
however, ePTFE sutures should be carefully handled during
surgery to avoid damaging them. In the tourniquet tech-
nique, a right-angled clamp can be replaced by any other
clamping devices such as a covered clamp, atraumatic
vascular clamp, or neurosurgery clip without losing the
advantages of this technique.
Another potential drawback is that the chordal length will
be affected by the left ventricular volume at the saline test.
If we fill the left ventricle too much, the chordal length
would be longer than it should be. Artificial chords that
are too long will cause residual prolapse or shallow coapta-
tion. Thus, we need to monitor the left ventricular volume
using TEE and determine the chordal length with the end-
systolic left ventricular volume.
The results from the present study showed a low inci-
dence of residual leaflet prolapse and recurrent leaflet pro-
lapse after mitral valve repair using the tourniquet
technique. Thus, the tourniquet technique is effective for
fixing prolapsing leaflets and maintaining the leaflets in po-
sition. However, our residual MR (defined as mild or greater
MR on the predischarge TTE) and recurrent MR (defined as
moderate or severe MR on any follow-up TTE after
discharge) rates were greater than the residual and recurrent
prolapse rates.
The echocardiographic findings indicated that most re-
sidual MR had resulted from poor coaptation, despite re-
paired leaflet prolapse. The potential causes of residual
poor coaptation included advanced degenerative changes
in the leaflet coaptation zone and insufficient coaptation
area. However, most of these cases of residual MR were
not detected by intraoperative TEE. We also used to assess
for residual MR partially on cardiopulmonary bypass,
which could have underestimated the MR. Our threshold
of using a second pump run for residual MR used to be
>2.0 cm2 of the regurgitant jet area, which seemed too opti-
mistic. We have modified our intraoperative assessment
protocol. Recently, we began measuring the coaptation
length using the ink test17 and intraoperative TEE to
confirm a sufficient postrepair coaptation area. Addition-
ally, we assess residual MR with cardiopulmonary bypassThe Journal of Thoracic and Caroff, and our threshold of a second pump run has been
changed to>1.0 cm2. These modifications and our technical
improvement have decreased our residual MR rate.
On the follow-up TTEs, we found that the most common
cause of recurrent MR was progressive degenerative
changes of the leaflet without recurrent prolapse. In partic-
ular, in the anterior leaflet prolapse and bileaflet prolapse
groups, this type of recurrent MR was often seen, and those
valves were found to have developed remarkable thickening
of the anterior leaflet and reduced mobility of the posterior
leaflet. Also, most valves with recurrent prolapse were asso-
ciated with progressive degenerative changes. The inci-
dence of recurrent MR was greater in the anterior leaflet
prolapse group than in the posterior leaflet and bileaflet pro-
lapse groups, compatible with previously reported find-
ings.18-20 No good method is available to control the
progression of degenerative changes. However, deep
coaptation at the primary mitral valve repair would seem
very important to maintain sufficient coaptation, even
after the leaflets have develop degenerative changes. Also,
minimizing residual MR will be important to reduce the
incidence of recurrent MR, because residual MR is a
known predictor of recurrent MR.20
The present study had the limitations of an observational
study. Because we did not compare the outcomes of the
tourniquet technique with those of other techniques, we
could not show the effect of this technique on the outcomes
of mitral valve repair. In some patients, the MR group was
evaluated semiquantitatively, which might have affected the
robustness of the outcomes measures. However, quantita-
tive measurements were not routinely performed in the
early years of the study period, and some raw echocardio-
graphic data were unavailable for measurement.CONCLUSIONS
The tourniquet technique is a simple effective method to
repair leaflet prolapse, with a low incidence of recurrent
prolapse. The incidence of recurrent MR was high in the
anterior leaflet prolapse group. Older age, no annuloplasty
ring or band used, and residual MR were strong predictors
of recurrent MR. Many cases of recurrent MR had resulted
from progressive degenerative changes of the leaflet
without recurrent prolapse.References
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FIGURE E1. The tourniquet technique. Small tourniquets hold artificial
chordae at a specific length temporarily, and competency is evaluated
with saline testing.
FIGURE E2. A tourniquet tube for the tourniquet technique.
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